Michael Bernas

Mr. Michael Bernas


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

23 March 2013 in Current Breast Cancer Reports
Verified
Journal Article
Closed access
PDF file
JAJane Armer
Jane Armer
JHJennifer Hulett
Jennifer Hulett
MBMichael Bernas
Michael Bernas
POPamela Ostby
Pamela Ostby
BSBob R. Stewart
Bob R. Stewart
JCJanice N. Cormier
Janice N. Cormier

5 May 2021 in Clinical & Experimental Metastasis
Verified
Journal Article
Closed access
PDF file
MBMichael Bernas
Michael Bernas
STSaskia R. J. Thiadens
Saskia R. J. Thiadens
PSPaula Stewart
Paula Stewart
JGJay Granzow
Jay Granzow

4 April 2005 in IEEE Engineering in Medicine and Biology Magazine
Verified
Journal Article
Closed access
MBMichael Bernas
Michael Bernas
MWM. White
M. White
BKB. Kriederman
B. Kriederman
PSP. Summers
P. Summers
CWC. Witte
C. Witte
Lymphedema (LE) afflicts hundreds of millions people worldwide. Manual lymph drainage, a specialized form of massage therapy, is an integral component - along with compression bandaging (CB) - of combined physical therapy (CPT), an internationally recommended optimal treatment. Experimental data from a rat model of obstructive LE suggests that massage alone can reduce LE volume as effectively as CB and CPT, at least early in the pathologic process. In a preliminary retrospective clinical study, it was also found that massage alone in a cohort of patients with mild stable upper-limb LE was as effective as CPT in volume reduction (massage 80.6 /spl plusmn/ 0.2% decrease compared to CPT 72.6 /spl plusmn/ 0.2%, mean /spl plusmn/ standard deviation, not significant). These initial studies lay the groundwork and evidence-based rationale for the design and implementation of the expanded, prospective randomized clinical trial of massage alone in various types and stages of LE in children and adults.

30 September 2023 in Clinical & Experimental Metastasis
Verified
Journal Article
Closed access
PDF file
MBMichael Bernas
Michael Bernas
SASara Al-Ghadban
Sara Al-Ghadban
STSaskia R. J. Thiadens
Saskia R. J. Thiadens
KAKaren Ashforth
Karen Ashforth
WLWalter C. Lin
Walter C. Lin
MMMargaret McNeely
Margaret McNeely

18 November 2021 in Lymphology
Verified
Journal Article
Open access
PDF file
DMD.J. Mustacich
D.J. Mustacich
RKRanjit Kylat
Ranjit Kylat
MBMichael Bernas
Michael Bernas
RMR.J. Myles
R.J. Myles
JJJ.A. Jones
J.A. Jones
PPP.W. Pires
P.W. Pires
Connexin proteins form gap junctions controlling exchange of ions and small molecules between cells and play an important role in movement of lymph within lymphatic vessels. Connexin47 (CX47) is highly expressed in lymphatic endothelial cells and CX47 missense mutations, i.e., R260C, cosegregate with primary lymphedema in humans. However, studies utilizing CX47 knockout mice have failed to demonstrate any lymphatic anomalies. To unravel the lymphatic consequences of expressing a mutant CX47 protein, we used CRISPR technology to create a mouse carrying a Cx47 missense mutation (Cx47R259C) equivalent to the human CX47R260C missense mutation associated with human primary lymphedema. Intradermal Evans Blue dye injection identified a 2-fold increase in regional lymph nodes in homozygous Cx47R259C mice compared to wildtype, particularly in the jugular region (4.8 ± 0.4 and 2.0 ± 0.0, respectively, p<0.01). Associated lymphatic channels were increased in Cx47R259C mice and mesenteric lymph reflux occurred in homozygous Cx47R259C mice but not in wildtype. Contractility of superficial cervical lymphatics, assessed by pressure myography, was reduced in homozygous Cx47R259C mice compared to wildtype. In conclusion, our data are the first to demonstrate a role for the Cx47 protein in lymphatic anatomy and function. This phenotype is similar to that found with other valve deficient mouse mutants, e.g., in Foxc2. Of significance, this study is the first to use CRISPR technology to develop a pre-clinical model of primary lymphedema and demonstrates the importance of distinguishing between lack of and presence of mutant protein when developing clinically relevant animal models for translation of pre-clinical findings.